Results 111 to 120 of about 99,900 (251)

Terminal S Wave Pattern in Lead V3 as a Simple Marker for Ventricular Tachycardia Risk Stratification in Patients With Repaired Tetralogy of Fallot

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Introduction Patients with repaired tetralogy of Fallot (rTOF) remain at risk of ventricular tachycardia (VT). This risk is most commonly related to slow conduction within the septal isthmus, which is defined as the region between the ventricular septal defect (VSD) patch and adjacent valvular annuli.
Yuki Matsuoka, Miyako Igarashi, Naoto Kawamatsu, Yuto Iioka, Yoshihiro Harano, Yuki Komatsu, Tomoko Machino‐Ohtsuka, Hiro Yamasaki, Tomoko Ishizu   +8 more
wiley   +1 more source

Tricuspid Regurgitation and Pulmonary Haemodynamics After Pulmonary Endarterectomy

OBJECTIVES: To assess tricuspid regurgitation evolution after pulmonary endarterectomy and to identify predictive factors for residual postoperative tricuspid regurgitation.
Vanhoof, Bram, Belge, Catharina, Van Langenhoven, Leen, Post, Marco C., Quarck, Rozenn A., De Meester, Pieter, Staal, Diederik P., Boerman, Sanne, Mager, Johannes J., Godinas, Laurent, Delcroix, Marion, Meyns, Bart, Verbelen, Tom, Hofman, Frederik N.   +13 more
core   +2 more sources

Chordae tendineae rupture: a rare cause of tricuspid regurgitation following coronary artery bypass grafting

BMC Anesthesiology
Background Tricuspid regurgitation is classified broadly by its etiology being either structural or functional. New or worsening tricuspid regurgitation upon weaning from cardiopulmonary bypass is rare and often functional. However, iatrogenic structural
Craig Stewart, Dana Wu, Jong Moo Steve Kim, Jian Ye, Julena Foglia   +4 more
doaj   +1 more source

Tricuspid annuloplasty prevents right ventricular dilatation and progression of tricuspid regurgitation in patients with tricuspid annular dilatation undergoing mitral valve repair [PDF]

, 2010
ObjectivesWe hypothesize that concomitant tricuspid annuloplasty in patients with tricuspid annular dilatation who undergo mitral valve repair could prevent progression of tricuspid regurgitation and right ventricular remodeling.MethodsIn 2002, 80 ...
Dion, R.A., Klautz, Robert J.M., Versteegh, Michel I.M., Robert J.M. Klautz, Versteegh, M.I.M., Van de Veire, Nico R., Bax, J.J., Michel I.M. Versteegh, Braun, Jerry, Delgado, Victoria, Bax, Jeroen J., Robert A. Dion, Jeroen J. Bax, Jerry Braun, Braun, J., Nico R. Van de Veire, Dion, Robert A., Victoria Delgado, Veire, N.R. van de, Klautz, R.J.M., Delgado, V.   +20 more
core   +1 more source

Standardized Reporting of Cardiac Magnetic Resonance Examinations in Children With Cardiac Diseases and Adults With Congenital Heart Disease: A Scientific Statement From the Association for European Pediatric and Congenital Cardiology (AEPC) and the International Society for Magnetic Resonance in Medicine (ISMRM)

Journal of Magnetic Resonance Imaging, EarlyView.
Francesca Raimondi, Inga Voges, Lamia Ait‐Ali, Sonya Babu‐Narayan, Rene Botnar, Barbara Burkhardt, Adrienne Campbell‐Washburn, Dominik Daniel Gabbert, Georg Hansmann, Willem A. Helbing, Hasan Hosan, Sylvia Krupickova, Heiner Latus, Duarte Martins, Colin McMahon, Christian Meierhofer, Vivek Muthurangu, Tiina Ojala, Pim van Ooij, Claudia Prieto, Milan Prsa, Kuberan Pushparajah, José F. Rodríguez Palomares, Samir Sarikouch, Lars Grosse‐Wortman, F. Gerald Greil, Heynric Grotenhuis   +26 more
wiley   +1 more source

Cardiac structure and function in psoriasis: A cross‐sectional analysis of the PSOCADIA study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Individuals with well‐treated psoriasis exhibited a higher burden of myocardial dysfunction (GLS < 16%) compared with controls, independent of cardiometabolic comorbidity. The prevalence was similar across psoriasis severity, highlighting the importance of cardiovascular assessment in all patients with psoriasis. Abstract Background Psoriasis is linked
Maria Dons, Morten Sengeløv, Kristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Mats C. H. Lassen, Sofie Bøgh‐Sørensen, Filip Soeskov Davidovski, Julie Borchsenius, Peter Schnohr, Gorm Boje Jensen, Rasmus Møgelvang, Christoffer V. Nissen, Peter Riis Hansen, Brittany N. Weber, Claus Zachariae, Lone Skov, Tor Biering‐Sørensen   +16 more
wiley   +1 more source

Reoperation for isolated rheumatic tricuspid regurgitation

, 2018
Background The reoperation for isolated tricuspid regurgitation in rheumatic population is rare and still unclear and controversial because of the rarity of publications.
Aniss Seghrouchni, Abdelatif Boulahya, Younes Moutakiallah, Mahdi Aithoussa, Zouhair Lakhal, Noureddine Atmani, Iliyasse Asfalou, Abdedaïm Hatim, Azeddine Moujahid   +8 more
core   +1 more source

Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation [PDF]

Zagazig University Medical Journal
Background: Tricuspid regurgitation (TR) is a valvular heart disorder characterized by the backward flow of blood from the right ventricle into the right atrium during systole, due to incomplete closure of the tricuspid valve.
Ismail Ibrahim, Tarek Naguib, Shehab Talaat, Hisham Roshdy   +3 more
doaj   +1 more source

First Experience With Extravascular Implantable Cardioverter‐Defibrillator Under Deep Sedation

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The Extravascular Implantable Cardioverter‐Defibrillator (EV‐ICD) utilizes a substernal lead to provide defibrillation and anti‐tachycardia pacing (ATP) while avoiding transvenous complications. General anesthesia (GA) was applied for implantation procedures in the EV‐ICD pivotal trial and is currently recommended by the ...
Nibras Soubh, Bernhard C. Danner, Ulrich Krause, Matthias J. Müller, Markus Zabel, Gerd Hasenfuß, Constanze Schmidt, Helge Haarmann, Eva Rasenack, Leonard Bergau   +9 more
wiley   +1 more source

Leadless Pacemaker Implantation in High‐Risk Patients: Real‐World Outcomes From a Multicenter Israeli Registry

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Introduction Transvenous pacemakers are effective but carry significant short‐ and long‐term complications. Leadless pacemakers were developed to overcome these limitations, however, data in high‐risk patients ineligible for transvenous systems remain limited.
Moshe Katz, Marianna Vander, David Luria, Moshe Rav Acha, Yoav Michowitz, Alon Barsheshet, Gregory Golovchiner, Roy Beinart   +7 more
wiley   +1 more source